(2R,2'R)-Diethyl 3,3'-disulfanediylbis(2-aminopropanoate)

Catalog No. :
ACSLJB894
CAS No. :
583-89-1
Molecular Formula :
C10H20N2O4S2
Molecular Weight :
296.41

IUPAC Name:diethyl 3,3'-disulfanediyl(2R,2'R)-bis(2-aminopropanoate)

(2R,2'R)-Diethyl 3,3'-disulfanediylbis(2-aminopropanoate) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$335.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,2'R)-Diethyl 3,3'-disulfanediylbis(2-aminopropanoate)
IUPAC Namediethyl 3,3'-disulfanediyl(2R,2'R)-bis(2-aminopropanoate)
MDL No.MFCD00056156
Molecular FormulaC10H20N2O4S2
Molecular Weight296.41
SMILESO=C(OCC)[C@@H](N)CSSC[C@H](N)C(OCC)=O
InChI KeyCIKFAVCRANPUES-YUMQZZPRSA-N
SynonymL-CYSTINE DIETHYL ESTER DIHYDROCHLORIDE;cystine,diethylester;3,3'-Dithiobis[(2R)-2-aminopropionic acid ethyl] ester;L-Cystine diethyl;L-Cystine diethyl ester;(2R,2'R)-Diethyl 3,3'-disulfanediylbis(2-aminopropanoate);L-CYSTINE DIETHYL ESTER 2HCL;L-Cystine, 1,1'-diethyl ester
CAS No.583-89-1
PubChem CID6993069

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSLJB894 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSLJB894 route product structure diagram
    ACSLJB894583-89-1
Inquiry

2. ACSLJB894 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCLPN641 route compound structure diagram
    ACCLPN641868-59-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSLJB894 route product structure diagram
    ACSLJB894583-89-1
Inquiry

Comments (0)